Comprehensive SRS Regenerex Tissue Attachment

Description

The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.

Conditions

Arthroplasty Complications, Osteo Arthritis Shoulders

Study Overview

Study Details

Study overview

The objective of this retrospective and prospective consecutive series data collection is to confirm safety, performance, and clinical benefits of the Comprehensive SRS Regenerex Tissue Attachment Augments when used for limb salvage arthroplasty.

PMCF Study to Provide Safety, Performance and Clinical Benefits Data of the Comprehensive Segmental Revision System (SRS) Regenerex Tissue Attachment Augments - A Retrospective Enrollment and Prospective Follow-up Consecutive Series Study

Comprehensive SRS Regenerex Tissue Attachment

Condition
Arthroplasty Complications
Intervention / Treatment

-

Contacts and Locations

Boca Raton

Toman Orthopedics and Sports Med, Boca Raton, Florida, United States, 33432

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient must be 18 years of age or older.
  • * Patient must be willing and able to follow directions.
  • * The Comprehensive Segmental Revision System was used in cases of:
  • 1. Non-inflammatory degenerative joint disease including osteoarthritis and avascular necrosis.
  • 2. Revision where other devices or treatments have failed.
  • 3. Correction of functional deformity.
  • 4. Oncology applications including bone loss due to tumor resection.
  • * Proximal or total humeral replacement, for: Treatment of acute or chronic fractures with humeral head (shoulder) involvement, which are unmanageable using other treatment methods.
  • * Distal or total humeral replacement for: Treatment of acute or chronic fractures with humeral epicondyle (elbow) involvement, which are unmanageable using other treatment methods.
  • * Biomet Comprehensive Segmental Revision System was used in a reverse application in patients whose shoulder joint has a grossly deficient rotator cuff with severe arthropathy and/or previously failed shoulder joint replacement with a grossly deficient rotator cuff for proximal humeral replacement. The patient must be anatomically and structurally suited to receive the implants and a functional deltoid muscle is necessary.
  • * The Comprehensive Segmental Revision System was used with bone cement in distal humeral and total humeral applications.
  • * Regenerex Tissue Attachment Augments were used in combination with the Comprehensive Segmental Revision System
  • * Absolute contraindications:
  • * Infection
  • * Sepsis
  • * Osteomyelitis
  • * Patient is a prisoner
  • * Patient is a current alcohol or drug abuser
  • * Patient has a psychiatric illness or cognitive deficit that will not allow for proper informed consent
  • * Patient is unwilling to consent
  • * Relative contraindications:
  • * Uncooperative patient or patient with neurologic disorders who is incapable of following directions
  • * Osteoporosis
  • * Metabolic disorders which may impair bone formation
  • * Osteomalacia
  • * Distant foci of infections which may spread to the implant site
  • * Vascular insufficiency, muscular atrophy, or neuromuscular disease
  • * The Comprehensive Segmental Revision System was used in a reverse shoulder application in patients receiving radiation therapy
  • * The Comprehensive Segmental Revision System was used without bone cement in distal humeral and total humeral applications.
  • * Regenerex Tissue Attachment Augments weren't used during the patient's surgery

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Zimmer Biomet,

Erin Osborn, STUDY_DIRECTOR, Zimmer Biomet

Study Record Dates

2026-12-31